Theratechnologies Inc
TSX:TH
Theratechnologies Inc
Interest Income Expense
Theratechnologies Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theratechnologies Inc
TSX:TH
|
Interest Income Expense
-$8.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Interest Income Expense
$18.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Interest Income Expense
$13.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Interest Income Expense
$4.1m
|
CAGR 3-Years
131%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Interest Income Expense
$13.7m
|
CAGR 3-Years
157%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
34%
|
|
Spectral Medical Inc
TSX:EDT
|
Interest Income Expense
-CA$3.2m
|
CAGR 3-Years
-373%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Theratechnologies Inc's Interest Income Expense?
Interest Income Expense
-8.1m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Interest Income Expense amounts to -8.1m USD.
What is Theratechnologies Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-22%
Over the last year, the Interest Income Expense growth was 3%. The average annual Interest Income Expense growth rates for Theratechnologies Inc have been -19% over the past three years , -22% over the past five years .